ESS505 Pre-hysterectomy Protocol: Safety and Short Term Effectiveness Study
ESS505 Pre-hysterectomy Protocol: Safety and Short Term Effectiveness Study
This study has been designed to evaluate an investigational model of the Essure System for Permanent Birth Control. The investigational device is designed to offer all the advantages of the currently approved device. In addition, the investigational device offers immediate, permanent contraception without a three-month waiting period or 90-day confirmation test. This study has been designed to evaluate the effectiveness of the investigational device in causing tubal occlusion from insert placement through three months of wearing.
This study has previously been posted by Conceptus, Inc. (US).
After acquiring Conceptus, Inc., Bayer HealthCare AG (Germany) is the sponsor of the trial.
Inclusion Criteria:
Exclusion Criteria: